Is growth hormone resistance/IGF-1 reduction good for you?

Cell Metab

Division of Endocrinology, Diabetes and Bone Disease, Samuel Bronfman Department of Medicine, Mount Sinai Medical Center, One Gustave L. Levy Place, Box 1055, New York, NY 10029, USA. Electronic address:

Published: April 2011

GH, IGF-1, and insulin are emerging as important and independent mediators of tumor development and aging. Two recent studies report that humans with GH-receptor deficiency are protected from developing cancer through alterations in GH, IGF-1, and insulin signaling, decreasing the susceptibility of cells to DNA damage and abnormal proliferation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2011.03.003DOI Listing

Publication Analysis

Top Keywords

igf-1 insulin
8
growth hormone
4
hormone resistance/igf-1
4
resistance/igf-1 reduction
4
reduction good
4
good you?
4
you? igf-1
4
insulin emerging
4
emerging independent
4
independent mediators
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!